Clinical outcome of deep-seated atypical lipomatous tumor of the extremities with median-term follow-up study

Eur J Surg Oncol. 2015 Mar;41(3):400-6. doi: 10.1016/j.ejso.2014.11.044. Epub 2014 Dec 3.

Abstract

Aims: There is no consensus on the best surgical treatment for deep-seated atypical lipomatous tumor (ALT) of the extremities; furthermore, the appropriate duration for follow-up observation remains unclear. We investigated clinical and functional median-term outcomes in the primary operations for ALT of the extremities in order to find its best treatment methods and observation periods.

Methods: From 1996 to 2009, we diagnosed 41 patients with deep-seated ALT of the extremities. Wide resection was performed on 11 patients and marginal resection was performed on 30 patients. The minimum follow-up was 5 years (median, 8.5; range, 5-17.4). Patients were evaluated for their local recurrence, dedifferentiation, and post-operative function using the ISOLS/MSTS scoring system.

Results: Recurrence and dedifferentiation rates were both 0% for the wide resection group, while the rates were 23% (7/30) and 3% (1/30) for the marginal resection group, respectively. Median duration before recurrence was 7.2 years (range, 4.0-14.2). Local recurrence-free survival rate was significantly higher in the wide resection group (P = 0.013). In the marginal resection group, 10% (3/30) of the cases showed residual tumor. The localization of these tumors was all intermuscular. The ISOLS/MSTS scores were 98% (range, 90-100) for wide resection and 99% (range, 93-100) for marginal resection, with no statistical difference (P = 0.694). No ALT-related deaths occurred during the observation period.

Conclusions: In addition to long-term (at least 8 years) of continuous observation, a wide resection is necessary in order to prevent recurrence, dedifferentiation, and residual tumor.

Keywords: Atypical lipomatous tumor; Extremities; Surgical method.

MeSH terms

  • Adult
  • Aged
  • Extremities
  • Female
  • Humans
  • Lipoma / pathology
  • Lipoma / surgery*
  • Liposarcoma / pathology
  • Liposarcoma / surgery*
  • Male
  • Middle Aged
  • Retrospective Studies
  • Soft Tissue Neoplasms / pathology
  • Soft Tissue Neoplasms / surgery*
  • Treatment Outcome